Allergan Finance LLC 8-K 2013
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): August 16, 2013
(Exact name of registrant as specified in its charter)
Morris Corporate Center III
400 Interpace Parkway
Parsippany, New Jersey 07054
(Address of principal executive offices)
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
(c) On August 16, 2013, Actavis, Inc. (the Company) announced the appointment of James DArecca to serve as the Chief Accounting Officer of the Company. The appointment of Mr. DArecca as the Chief Accounting Officer of the Company was not made pursuant to any arrangement or understanding between him and any other person. Mr. DArecca, age 42, joins the Company from Bausch & Lomb where he served in a capacity similar to his new position since May 2013. Prior to Bausch & Lomb, Mr. DArecca worked for Merck & Co from 2010 to May 2013, where he served as Executive Director & Business Development Controller. In this role, he served as the primary liaison between the Controllers organization and the business development and corporate licensing functions. Prior to joining Merck, Mr. DArecca was Executive Director & Assistant Controller at Schering-Plough from 2005 to 2009. He also spent 13 years with PricewaterhouseCoopers, with an industry focus on pharmaceuticals, medical devices and consumer products. Mr. DArecca is a Certified Public Accountant.
Mr. DArecca will receive salary, bonus and future equity opportunity, and will participate in other benefit and compensation plans, at levels consistent with his position and scope of responsibility. Mr. DArecca was provided a cash sign-on bonus in an amount that is commensurate with his position and scope of responsibility, payable in two equal installments on the six-month anniversary of his hiring and the one-year anniversary of his hiring.
A copy of the Companys press release announcing Mr. DAreccas appointment as the Companys Chief Accounting Officer is attached hereto as Exhibit 99.1.
Exhibit 99.1 Press Release of the Company dated August 16, 2013
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 16, 2013